Es el mayor fabricante del mundo de anticuerpos y proteínas recombinantes. La misión de Abnova es la producción y aplicación de los anticuerpos derivados de: "un gen un anticuerpo", traducción del genoma humano completo. El primer objetivo de la compañía es la disponibilidad de anticuerpos para el mercado de investigación mediante la adopción de un enfoque de todo el genoma para la producción de alto rendimiento de proteína humana y anticuerpos.
Esta diversificada en varios campos:
Mouse monoclonal antibody raised against a full-length recombinant AKR7A2.
Rabbit polyclonal antibody raised against partial recombinant AKR7A2.
Mouse polyclonal antibody raised against a full-length human AKR7A2 protein.
Rabbit polyclonal antibody raised against a full-length human AKR7A2 protein.
Human AKR7A3 (AAH25709, 1 a.a. - 331 a.a.) full-length recombinant protein with His tag expressed in Escherichia coli.
Human AKR7A3 (AAH25709, 1 a.a. - 331 a.a.) full length recombinant protein expressed in Escherichia coli.
Mouse monoclonal antibody raised against full length recombinant AKR7A3.
Mouse polyclonal antibody raised against a full-length human AKR7A3 protein.
Rabbit recombinant monoclonal antibody raised against of human AKT.
AKT Phospho-Specific Array includes 137 highly specific and well-characterized phosphorylation antibodies in the AKT pathway.
AKT/PKB Signaling Phospho-Specific Array includes 216 highly specific and well-characterized phosphorylation antibodies in the AKT/PKB signaling pathway.
This protein protein interaction antibody pair set comes with two antibodies to detect the protein-protein interaction, one against the AKT1 protein, and the other against the BAD protein for use in in situ Proximity Ligation Assay. See Publication Reference below.